 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 1300
H.P. 897 House of  Representatives,  April 4, 2017
An Act  To Require  a Prescription for a Medication That  Contains 
Certain Substances That  May Be Used To Make Methamphetamine
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative COOPER  of Yarmouth.
Cosponsored by Senator CARPENTER of Aroostook and
Representative: LUCHINI of Ellsworth.

 
 Page 1 - 128LR0194(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  17-A MRSA §1101, sub -§4-A, as enacted by PL 2005, c. 430, §1 and 2 
affected by §10, is amended to read:  3 
4-A.   "Methamphetamine precursor drug" means any drug or product possessed by a 4 
person that contains ephedrine or pseudoephedrine or their salts, isomers or salts of 5 
isomers, either alone or in combination with other ingredients, in dry or solid nonliquid 6 
form, or that contains  in the aggregate a quantity of more than 9 grams of ephedri ne, 7 
pseudoephedrine or  phenylpropanolamine or their its salts, isomers or salts of isomers, 8 
either alone or in combination with other ingredients, in dry or solid nonliquid form.  9 
Sec. 2.  32 MRSA §13702 -A, sub -§33, as enacted by PL 2007, c. 402, Pt. DD, 10 
§2, is amended to read:  11 
33.  Targeted methamphetamine precursor.  "Targeted methamphetamine 12 
precursor" means any product containing any amount of ephedrine, pseudoephedrine or  13 
phenylpropanolamine or their its salts, isomers or salts of isomers, either alone or in 14 
combination with other ingredients:  15 
A.  In dry or solid nonliquid form; or  16 
B.  In liquid, liquid -filled capsule or glycerin matrix form if designation as a targeted 17 
methamphetamine precursor has been completed by rule adopted pursuant to section 18 
1379 5, subsection 5, paragraph A.  19 
Sec. 3.  32 MRSA §13795, sub -§5, ¶A, as amended by PL 2011, c. 657, Pt. AA, 20 
§84, is further amended to read:  21 
A.  If the Director of the Maine Drug Enforcement Agency within the Department of 22 
Public Safety finds that the ease o f availability of liquid, liquid -filled capsule or 23 
glycerin matrix forms of products containing ephedrine, pseudoephedrine or  24 
phenylpropanolamine or their its salts, isomers or salts of isomers, either alone or in 25 
combination with other ingredients, referr ed to in this paragraph as "products," is a 26 
threat to the public health, safety and welfare, then the Director of the Maine Drug 27 
Enforcement Agency shall notify the Commissioner of Health and Human Services.  28 
The Commissioner of Health and Human Services s hall consult with the joint 29 
standing committee of the Legislature having jurisdiction over health and human 30 
services matters, providing the reasons for undertaking rulemaking, and may, after 31 
consultation, adopt rules designating the products as targeted me thamphetamine 32 
precursors pursuant to section 13702 -A, subsection 33, paragraph B.  33 
Sec. 4.  32 MRSA §13796, sub -§3, as amended by PL 2011, c. 584, §3, is further 34 
amended to read:  35 
3.  Restrictions on the sale of targeted methamphetamine precursors.   The 36 
following restrictions on location in the retail store, manner of sale and amount of sale 37 
apply to sales of targeted methamphetamine precursors.  The limits under this subsection 38 
on the amount of targeted methamphetamine precursors that may be sold apply to th e 39 
 
 Page 2 - 128LR0194(01) -1 
 total amount of base ephedrine, phenylpropanolamine and  pseudoephedrine contained in 1 
packages and not the overall weight of the packages.  2 
A.  A retailer may not sell to the same person a targeted methamphetamine precursor 3 
that causes the sales to that pe rson of targeted methamphetamine precursors within a 4 
24-hour period to exceed 3.6 grams.  5 
A-1.  A person may not purchase more than 3.6 grams of a targeted 6 
methamphetamine precursor within a 24 -hour period.  7 
A-2.  A retailer may not sell to the same person a  targeted methamphetamine 8 
precursor that causes the sale to that person of targeted methamphetamine precursors 9 
within a 30 -day period to exceed 9 grams.  10 
A-3.  A person may not purchase more than 9 grams of a targeted methamphetamine 11 
precursor within a 30 -day period.  12 
B.  Except with regard to single -dose packages of not more than 60 milligrams that 13 
are kept within 30 feet and in direct line of sight of a staffed cash register or store 14 
counter, a retailer shall keep targeted methamphetamine precursors in a lo cation that 15 
is locked or otherwise not accessible by customers.  16 
C.  Except with regard to single -dose packages of not more than 60 milligrams that 17 
are kept within 30 feet and in direct line of sight of a staffed cash register or store 18 
counter, the sale of targeted methamphetamine precursors must be completed by:  19 
(1)  A licensed pharmacist or licensed pharmacy technician; or  20 
(2)  An employee of the retailer who accepts payment for the targeted 21 
methamphetamine precursor as long as:  22 
(a) The employee works unde r the direct supervision of a pharmacist in the 23 
pharmacy area of the retail store; and  24 
(b)  A licensed pharmacist or licensed pharmacy technician has given 25 
individual, express approval for the purchase.  26 
D.  Except with regard to single -dose packages of not  more than 60 milligrams that 27 
are kept within 30 feet and in direct line of sight of a staffed cash register or store 28 
counter, a retailer shall require a person purchasing a targeted methamphetamine 29 
precursor to present a valid government -issued photograph  identification document at 30 
the point of sale.  A retailer shall record the:  31 
(1)  Name and address of the purchaser;  32 
(2)  Name of the targeted methamphetamine precursor purchased including the 33 
number of grams the product contains;  34 
(3)  Date and time of pu rchase; and  35 
(4)  Form of identification presented, issuing government entity and 36 
corresponding identification number.  37 
E.  Except with regard to single -dose packages of not more than 60 milligrams that 38 
are kept within 30 feet and in direct line of sight of a staffed cash register or store 39 
counter, a retailer shall maintain a written or electronic logbook and require a person 40 
 
 Page 3 - 128LR0194(01) -1 
 purchasing a targeted methamphetamine precursor to sign the logbook.  A purchaser 1 
must sign the logbook acknowledging that the purchase r understands the applicable 2 
sales limit and that providing false statements or misrepresentations in the logbook 3 
may subject the purchaser to criminal penalties under 18 United States Code, Section 4 
1001.  5 
SUMMARY  6 
This bill requires a prescription to posses s any amount of ephedrine or 7 
pseudoephedrine.  It removes references to ephedrine and pseudoephedrine from the laws 8 
governing over -the-counter sales of methamphetamine precursors.  9 
 
